Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × siltuximab × Clear all

NCT05316116 2026-02-05

Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)

Phase EARLY_PHASE1 Terminated

Other hematologic neoplasm

Leukemia, Large Granular Lymphocytic

NCT02805868 2016-10-24

Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Phase EARLY_PHASE1 Withdrawn

Classical hematologyLymphoidMyeloid

Anemia, Lymphoma, Follicular, Polycythemia Vera, Thrombocytopenia, Thrombocytosis, Primary Myelofibrosis